• Explore /
  • Poster
  • / Allogeneic stem cell transplantation (AlloSCT) for patients (pts) with acute leukemia following venetoclax-based therapy.

Allogeneic stem cell transplantation (AlloSCT) for patients (pts) with acute leukemia following venetoclax-based therapy.

Abstract Poster

Authors

null

Akash Mukherjee

The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, TX

Akash Mukherjee , Denai R. Milton , Elias Jabbour , Marina Konopleva , Courtney Denton Dinardo , Alison Gulbis , Farhad Ravandi , Naval Guastad Daver , Tapan M. Kadia , Betul Oran , Uday R. Popat , Stefan O. Ciurea , Jin Im , Partow Kebriaei , Rohtesh S. Mehta , Hagop M. Kantarjian , Richard E. Champlin , Issa F. Khouri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Allogenic Stem Cell Transplantation

Citation

J Clin Oncol 37, 2019 (suppl; abstr 7047)

DOI

10.1200/JCO.2019.37.15_suppl.7047

Abstract #

7047

Poster Bd #

422

Abstract Disclosures

Similar Posters

First Author: Maria Amaya

First Author: Omar Albanyan

First Author: Marcus Messmer

First Author: Nicholas James Short